Quick Answer
Microbot Medical Inc. reported Net Income Loss of -$13.14 million for the year ending 2025.
- Microbot Medical Inc. showed a decrease of -14.8% in Net Income Loss from 2024 to 2025.
- This data is from Microbot Medical Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2009 to 2025), Microbot Medical Inc.'s Net Income Loss has grown by 51.4%.
- Historical annual values: Fiscal year 2025: -$13.14 million | Fiscal year 2024: -$11.44 million | Fiscal year 2023: -$10.74 million | Fiscal year 2022: -$13.17 million | Fiscal year 2021: -$11.31 million | Fiscal year 2020: -$9.17 million | Fiscal year 2019: -$7.25 million | Fiscal year 2018: -$7.26 million | Fiscal year 2017: -$7.59 million | Fiscal year 2016: -$9.66 million | Fiscal year 2015: -$921.0 thousand | Fiscal year 2014: -$32.74 million | Fiscal year 2014: -$32.74 million | Fiscal year 2013: -$26.44 million | Fiscal year 2012: -$28.49 million | Fiscal year 2011: -$21.33 million | Fiscal year 2010: -$25.24 million | Fiscal year 2009: -$27.03 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: